Yong Sok Kwon

Array ( [id] => 54202 [patent_doc_number] => 07767702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Substituted oxazolidinones for combinational therapy' [patent_app_type] => utility [patent_app_number] => 10/481297 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25672 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767702.pdf [firstpage_image] =>[orig_patent_app_number] => 10481297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688909 [patent_doc_number] => 20030032634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance' [patent_app_type] => new [patent_app_number] => 10/159280 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 11671 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032634.pdf [firstpage_image] =>[orig_patent_app_number] => 10159280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688893 [patent_doc_number] => 20030032618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Pharmaceutical combinations' [patent_app_type] => new [patent_app_number] => 10/148526 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4009 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032618.pdf [firstpage_image] =>[orig_patent_app_number] => 10148526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774737 [patent_doc_number] => 20030018075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite' [patent_app_type] => new [patent_app_number] => 10/158059 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8175 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018075.pdf [firstpage_image] =>[orig_patent_app_number] => 10158059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6414422 [patent_doc_number] => 20020183377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Use of melatonin for treating androgenetic and diffuse alopecia' [patent_app_type] => new [patent_app_number] => 10/130297 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5022 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183377.pdf [firstpage_image] =>[orig_patent_app_number] => 10130297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122942 [patent_doc_number] => 07704948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 10/479069 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5381 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704948.pdf [firstpage_image] =>[orig_patent_app_number] => 10479069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736124 [patent_doc_number] => 20030013759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Methods for selectively occluding blood supplies to neoplasias' [patent_app_type] => new [patent_app_number] => 10/154625 [patent_app_country] => US [patent_app_date] => 2002-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7398 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013759.pdf [firstpage_image] =>[orig_patent_app_number] => 10154625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856821 [patent_doc_number] => 20030130322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Combination treatment for alcoholism and alcohol dependence' [patent_app_type] => new [patent_app_number] => 10/153379 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16235 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130322.pdf [firstpage_image] =>[orig_patent_app_number] => 10153379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721416 [patent_doc_number] => 20030055106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Therapeutic uses of peroxometallic compounds' [patent_app_type] => new [patent_app_number] => 10/150756 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15254 [patent_no_of_claims] => 135 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055106.pdf [firstpage_image] =>[orig_patent_app_number] => 10150756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 745309 [patent_doc_number] => 07026356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Fatty acid analogues for the treatment of diseases caused by the pathological proliferation of smooth muscle cells' [patent_app_type] => utility [patent_app_number] => 10/151203 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5591 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026356.pdf [firstpage_image] =>[orig_patent_app_number] => 10151203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774739 [patent_doc_number] => 20030018077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease' [patent_app_type] => new [patent_app_number] => 10/146919 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4171 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018077.pdf [firstpage_image] =>[orig_patent_app_number] => 10146919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684031 [patent_doc_number] => 20030119895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia' [patent_app_type] => new [patent_app_number] => 10/150546 [patent_app_country] => US [patent_app_date] => 2002-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41833 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119895.pdf [firstpage_image] =>[orig_patent_app_number] => 10150546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770508 [patent_doc_number] => 20030216448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Treatment of neuropathic pain' [patent_app_type] => new [patent_app_number] => 10/145681 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6938 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216448.pdf [firstpage_image] =>[orig_patent_app_number] => 10145681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814155 [patent_doc_number] => 20030073705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Method of treatment' [patent_app_type] => new [patent_app_number] => 10/143415 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8368 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073705.pdf [firstpage_image] =>[orig_patent_app_number] => 10143415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642673 [patent_doc_number] => 20030103983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Ace inhibitor-vasopressin antagonist combinations' [patent_app_type] => new [patent_app_number] => 10/130168 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7851 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103983.pdf [firstpage_image] =>[orig_patent_app_number] => 10130168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1193266 [patent_doc_number] => 06730702 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-04 [patent_title] => 'Therapeutic agents for inflammatory diseases of intestine' [patent_app_type] => B1 [patent_app_number] => 10/129361 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4852 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730702.pdf [firstpage_image] =>[orig_patent_app_number] => 10129361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537995 [patent_doc_number] => 20020193404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Use of bicyclic heterocycles for the treatment and prevention of arterial thrombotic disease' [patent_app_type] => new [patent_app_number] => 10/137895 [patent_app_country] => US [patent_app_date] => 2002-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1342 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193404.pdf [firstpage_image] =>[orig_patent_app_number] => 10137895 [rel_patent_id] =>[rel_patent_doc_number] =>)